Clinical Trial Update: Cerebrotendinous Xanthomatosis (CTX) Prevalence Study

View source ↗

Summary

A clinical trial update shows that the prevalence study for cerebrotendinous xanthomatosis (CTX) has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrotendinous Xanthomatosis

Snippet

Sponsor: Travere Therapeutics, Inc. | Conditions: Cerebrotendinous Xanthomatosis (CTX) | Status: COMPLETED | Results posted: 2024-09-19